- Cipla has received final approval for its abbreviated new drug application for Efavirenz tablets 600mg from the USFDA.
- It is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 infection in adults,
.
No comments:
Post a Comment